Covid: Remdesivir ‘has little or no effect’ on survival, says WHO

World World news
Share with others

For its Solidarity clinical trial, the WHO tested the effects four potential treatments – remdesivir, an Ebola drug, was one, but they also looked at malaria drug hydroxychloroquine, auto-immune drug interferon, and the HIV drug combination of lopinavir and ritonavir.

Did you think this article was useful?

Click on the star to vote

Average vote 0 / 5. Number of votes: 0

No votes so far